Status:
NOT_YET_RECRUITING
Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy
Lead Sponsor:
University of Nebraska
Conditions:
Carbon Monoxide Poisoning
Carbon Monoxide Intoxication
Eligibility:
All Genders
19+ years
Phase:
PHASE1
PHASE2
Brief Summary
Hyperbaric Oxygen Therapy (HBO) is routine treatment of carbon monoxide (CO) poisoning to prevent delayed neurological sequelae. This study looking to see if neurologic outcomes are improved with the ...
Detailed Description
Hyperbaric Oxygen Therapy (HBO) is routine treatment of carbon monoxide (CO) poisoning to prevent delayed neurological sequelae. This study looking to see if neurologic outcomes are improved with the ...
Eligibility Criteria
Inclusion
- Acute CO poisoning, intentional or non-intentional exposure, receiving HBO treatment during hospitalization
- Age \>18 years
- Nebraska Medicine admission
Exclusion
- Mechanical ventilation
- No hospital admission or admission to hospital Critical Care Medicine Service
- Allergy to dexamethasone
- Pre-Existing neurological condition confounding outcome determination
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06574048
Start Date
January 1 2026
End Date
January 1 2028
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nebraska Medicine, Hyperbaric Medicine Program, Clarkson Tower
Omaha, Nebraska, United States, 68105